The Stock Market is Being Rocked by the Biggest Shake-up in a Generation as Tech Falls Behind

Dow Jones49 minutes ago

Investors' sudden souring on the artificial-intelligence theme has coincided with a newfound fondness for shares of drugmakers and purveyors of consumer essentials like toothpaste and laundry detergent.

The shift has triggered one of the most dramatic stock-market shake-ups in decades. Not since the immediate aftermath of the dot-com bubble more than two decades ago have investors seen normally sleepy healthcare stocks outperform red-hot technology names by such a wide margin.

During the 100 days through Nov. 10, stocks in the S&P 500's healthcare sector outperformed the index's information-technology names by more than 33 percentage points, according to an analysis by Dow Jones Market Data.

That was the widest outperformance since October 2001. By then, the dot-com bubble had already burst, and major indexes were mired in a painful bear market made worse by the Sept. 11 terrorist attacks and a mild economic recession. As major indexes like the S&P 500 SPX and the Nasdaq Composite COMP struggled at the time, shares of Walmart (WMT) and other defensive stocks rallied.

As of Wednesday's close, healthcare was still outperforming tech by more than 22 percentage points - what would be its strongest relative performance since 2008, excluding earlier this year, Dow Jones Market Data showed.

Gina Martin Adams, chief market strategist at HB Wealth, framed the shift as merely a reversal of what investors had witnessed during the first half of 2026, when shares of semiconductor stocks and other "AI suppliers" zoomed higher at a pace that drew comparisons to the final leg of the dot-com bubble in late 1999.

"After what we saw in semiconductors in May and June, it makes sense that the reversal would be just as powerful," Martin Adams said during a conversation with MarketWatch.

The recent changing of the guard could be a buying opportunity for investors who regret not being more heavily exposed to the AI theme. Nicholas Colas, co-founder of DataTrek, wrote in commentary shared with MarketWatch that other recent extremes in the relationship between tech and healthcare stocks have been followed by sharp reversals.

Risk is cheap. Safety isn't.

Tech's recent troubles have turned another longstanding relationship in markets on its head.

Based on forward price-to-earnings ratio - a popular valuation metric used by Wall Street analysts - consumer staples XX:SP500.30 and healthcare are both trading at a premium to tech. This represents "a big divergence" from the dominant trend of the past decade, DataTrek's Colas pointed out.

Put another way, information-technology companies are extremely cheap relative to their expected earnings growth, while defensive staples are expensive. Other metrics tell a similar story.

Short-term momentum gauges like relative strength indexes show that tech stocks are oversold while staples are overbought, said Michael Lebowitz, a portfolio manager at RIA Advisors, during a conversation with MarketWatch.

"Risk is cheap, but safety is expensive," Lebowitz told MarketWatch on Wednesday.

As of earlier this week, the S&P 500 information-technology sector was trading at 16.9 times expected earnings over the next 12 months, its lowest forward price-to-earnings ratio since March 2020. Consumer staples were trading at nearly 25 times, while healthcare was at 19 times. This is also "a big divergence" from the dominant trend of the past decade, Colas noted.

The big question for investors right now is whether or not this rotation is just the latest to emerge since the start of this AI-driven bull market. Investors saw something similar in the summer of 2024, and again during the fourth quarter of 2025.

HB Wealth's Martin Adams said the latest market action was giving her a feeling of déjà vu, as investors were discussing many of the same themes and potential pitfalls late last year, when nontech stocks were having an earlier moment in the spotlight.

Lebowitz used the examples of Walmart and Nvidia (NVDA) to illustrate his point. Walmart is now trading at a forward price-to-earnings ratio above 45, while Nvidia's is around 16.

"Nvidia doesn't need much growth to be a better buy than Walmart here," Lebowitz said. "Unless there's a lot more to this whole Nvidia thing than meets the eye. That's the risk."

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment